Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment.
Reda M, Ngamcherdtrakul W, Nelson MA, Siriwon N, Wang R, Zaidan HY, Bejan DS, Reda S, Hoang NH, Crumrine NA, Rehwaldt JPC, Bindal A, Mills GB, Gray JW, Yantasee W.
Reda M, et al. Among authors: wang r.
Nat Commun. 2022 Jul 23;13(1):4261. doi: 10.1038/s41467-022-31926-9.
Nat Commun. 2022.
PMID: 35871223
Free PMC article.